Iwaki & Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Iwaki & Co., Ltd. with three other
companies in this sector in Japan:
Zeria Pharmaceutical Co Ltd
sales of 64.85 billion Japanese Yen [US$570.03 million]
of which 53%
was Pharmaceuticals Business),
CMIC Holdings Co Ltd
(65.28 billion Japanese Yen [US$573.83 million]
of which 52%
was Cro Business), and
Torii Pharmaceutical Co., Ltd.
(64.14 billion Japanese Yen [US$563.75 million]
of which 100%
Iwaki & Co., Ltd. reported sales of ¥57.39 billion (US$504.44 million)
November of 2017.
increase of 4.1%
versus 2016, when the company's sales were ¥55.12 billion.